This information is not based on any clinical or national mortality data - it is a mathematical model based off of an unreliable secondary analysis of the WHI trial in which researchers went back, spliced up the patients by age, and then tried to tease out a benefit for estrogen not seen in the group as a whole. Sarrel, who created these dubious calculations, is a paid consultant for Noven Pharmaceuticals, which just HAPPENS to manufacture an estrogen patch.
The WHI has been maimed repeatedly by critics who simply didn't like the study's results, which showed
No comments:
Post a Comment